Introduction: Diabetes retinopathy is a leading cause of blindness. According to "Statistics on blindness in the Model Reporting Area 1969-70," diabetic retinopathy was responsible for 11.1% of all new cases of legal blindness and 19.1% of those aged 20-64 years. The study objectives were to investigate diabetic retinopathy in the context of age of onset of diabetes, duration of diabetes, and metabolic control, to investigate the relationship of diabetic retinopathy with age and gender of the patients, to investigate the different stages of retinopathy and their analysis, and to investigate the benefits of fluorescein angiography.
Methods: This one-year retrospective study was carried out at SCB Medical College, Cuttack, Odisha. After pupillary dilatation with a combination of phenylephrine and tropicamide eye drops (e.g. Tropicacyl plus eyedrops), the initial examination began with a fundus inspection with a direct ophthalmoscope. To avoid cardiovascular problems, effort was taken to rule out hypertension in the patient before administering these eyedrops.
Results: The current study included data from 50 diabetic patients who visited SCB Medical College, Cuttack, Odisha outpatient department or were hospitalised within a one-year period.
Conclusion: Fundus Fluorescein Angiography is a valuable auxiliary diagnostic method. The procedure is useful in the diagnosis, treatment, documentation, and follow-up of patients, as well as in keeping a permanent record of the stages of retinopathy, which is useful in understanding the course of the disease in the patient, as well as the patient's response to treatment and follow-up.
Key words: Diabetic Retinopathy, FFA, Fluorescein, PDR, NPDR, Maculopathy, FAZ, CSME, Microaneurysms, NVD, NVE
|
